Jump to main content.
Fact Sheet: Allocation of Essential Use Allowances for
Calendar Year 2006
Action
- In accordance with the
Montreal Protocol on Substances that Deplete the Ozone
Layer and the Clean Air Act, EPA is allocating
essential use allowances to permit U.S. companies to obtain
limited quantities of certain ozone-depleting substances
(ODS) that have been phased out of production.
- This final action proposes an allocation of essential
use allowances for chlorofluorocarbons (CFCs) to U.S.
pharmaceutical companies for the manufacture of metered
dose inhalers for the treatment of asthma and chronic
obstructive pulmonary disease.
- The allocations are based on the Food and Drug
Administration's (FDA) determination that 1002.4 metric
tonnes of CFCs are necessary for use in metered dose
inhalers for the year 2006.
Background
- Essential use allowances enable a person to obtain a
controlled class I ODS as part of an exemption to the
regulatory ban on the production and import of these
chemicals, which became effective on January 1, 1996 .
- Under the Montreal Protocol, exemptions may be granted
for uses that are determined by the Parties to be
"essential." Decision IV/25, taken by the Parties to the
Protocol in 1992, established criteria for determining
whether a specific use should be approved as essential, and
set forth the international process for making
determinations of essentiality.
- EPA allocates essential use allowances for exempted
production or import of a specific quantity of a class I
ODS solely for the designated essential purpose.
For Further Information
Top of page
Jump to main content.